CX Institutional’s Balchem Corp BCPC Stock Holding History

CX Institutional’s Portfolio BCPC Stock Details BCPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,655	Closed	-$935K	–	607
2022 Q4	$935K	Buy	+7,655	New	+$1.01M	0.06%	285

Other funds holding BCPC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CX Institutional's BCPC Position: Q1 2023 in Review

CX Institutional sold out of Balchem Corp (BCPC) in Q1 2023, closing a stake of 7,655 shares — an estimated $935K sold.

CX Institutional first reported a position in BCPC in Q4 2022 and held it in 1 quarter. The position peaked at $935K in Q4 2022. 281 funds tracked by Wall St. Rank hold BCPC as of Q1 2023.

CX Institutional reported no remaining Balchem Corp position as of Q1 2023 after selling out during the quarter.
CX Institutional sold 7,655 Balchem Corp shares in Q1 2023, an estimated $935K.
CX Institutional first reported a position in Balchem Corp in Q4 2022 and held it in 1 quarter.
CX Institutional's Balchem Corp position peaked at $935K in Q4 2022.
281 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2023.

Based on CX Institutional's 13F filing for Q1 2023, filed 4 May 2023.